在检测认知障碍方面评估基于网络和临床主观认知衰退评估的准确性:多队列研究
Jae Myeong Kang1,2,3, Manchumad Manjavong1,3,4, Adam Diaz1,5,6
1VA Advanced Imaging Research Center, San Francisco VA Medical Center, San Francisco, CA, United States.
Journal of medical Internet research
|August 11, 2025
概括
基于网络的认知评估,包括日常认知量表 (ECog) 和其缩写形式 (ECog12),与诊所内测试一样有效,用于识别认知障碍 (CI). 这证实了阿尔茨海默病和相关痴呆症的远程查.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 医疗信息学 医疗信息学
背景情况:
- 可扩展的工具对于识别阿尔茨海默病和相关痴呆症的认知障碍 (CI) 是至关重要的.
- 日常认知量表 (ECog) 和其简称 (ECog12) 通过评估主观认知和功能变化来预测CI.
- 基于网络的认知测试提供了方便和可扩展的CI识别,但它们的远程有效性需要进一步研究.
研究的目的:
- 在区分CI和认知正常 (CU) 个体方面,比较基于网络和临床的ECog.
- 与全长ECog.相比,评估基于Web的ECog12的有效性.
主要方法:
- 利用基于网络的脑健康登记 (BHR) 和临床阿尔茨海默病神经成像计划 (ADNI) 的数据.
- 使用接收器操作特征 (ROC) 曲线评估自我报告的ECog (Self-ECog),研究合作伙伴报告的ECog (SP-ECog) 和它们的12项版本 (ECog12).
- 基于网络和临床环境之间的ROC曲线 (AUC) 下的比较面积,以及使用DeLong测试进行ECog和ECog12之间的比较.
主要成果:
- 基于网络的自我ECog (AUC=0.722) 和SP-ECog (AUC=0.818) 有效地将CI与CU进行了歧视.
- 基于网络的ECog12版本也显示了区分能力 (自我ECog12 AUC=0.709,SP-ECog12 AUC=0.777).
- 对于自我报告和研究合作伙伴报告的措施,在基于网络和临床的ECog AUC之间没有发现显著差异,在基于网络的环境中也没有发现全长和简短的ECog AUC.
结论:
- 基于网络的ECog分数 (完整和简短的形式) 与临床分数一样有效,用于识别临床诊断的CI.
- 在基于网络的环境中,ECog12与全长ECog同样有效用于CI识别,提供了一个具有成本效益的,可扩展的选工具.
- 基于网络的ECog有助于在偏远环境中早期发现CI,帮助及时转诊进行评估和潜在的疾病修饰疗法.
关键词:
在ECog-12中使用.每天的认知度量表 认知度量表在MCI中,MCI是MCI.痴呆症 痴呆症是一种痴呆症.轻度的认知障碍 轻度的认知障碍在线在线在线 在线在线在线在线主观认知衰退 主观认知衰退基于网络的基于网络的更多相关视频
相关概念视频
Cognitive Development During Adulthood
275
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
275
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
206
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
206
Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165


